Hester Biosciences Ltd Half Yearly Results

Gross Sales

165.96

146.24

158.31

142.24

123.85

Excise Duty

0

0

0

0

0

Net Sales

165.96

146.24

158.31

142.24

123.85

Other Operating Income

0

0

0

0

0

Other Income

4.88

6.82

8.42

9.85

9.71

Total Income

170.84

153.06

166.73

152.1

133.55

Total Expenditure

129.15

120.16

130.73

111.81

103.67

PBIDT

41.69

32.9

36

40.29

29.88

Interest

10.9

9.13

10.64

5.26

4.06

PBDT

30.8

23.77

25.36

35.02

25.83

Depreciation

8.34

7.49

9.68

10.61

10.09

Minority Interest Before NP

0

0

0

0

0

Tax

6.46

5.65

5.07

5.49

5.79

Deferred Tax

0.13

0.21

-0.15

1.06

-0.22

Reported Profit After Tax

15.88

10.42

10.75

17.87

10.16

Minority Interest After NP

1.34

1.48

0.8

2.16

-0.75

Net Profit after Minority Interest

14.54

8.93

9.96

15.72

10.91

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

14.54

8.93

9.96

15.72

10.91

EPS (Unit Curr.)

18.66

10.5

12.64

18.48

11.95

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

8.51

8.51

8.51

8.51

8.51

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

25.12

22.49

22.74

28.32

24.12

PBDTM(%)

-

-

-

-

-

PATM(%)

9.56

7.12

6.79

12.56

8.2